Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials

OBJECTIVES: To assess the cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients without diabetes. METHODS: We searched PubMed, MEDLINE, Embase and Cochrane Library for publications up to 17 August 2022. Certainty of evidence was assessed using...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Wan-Chuan, Hsu, Shih-Ping, Chiu, Yen-Ling, Yang, Ju-Yeh, Pai, Mei-Fen, Ko, Mei-Ju, Tu, Yu-Kang, Hung, Kuan-Yu, Chien, Kuo-Liong, Peng, Yu-Sen, Wu, Hon-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577928/
https://www.ncbi.nlm.nih.gov/pubmed/36241355
http://dx.doi.org/10.1136/bmjopen-2021-060655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577928/
https://www.ncbi.nlm.nih.gov/pubmed/36241355
http://dx.doi.org/10.1136/bmjopen-2021-060655

Ejemplares similares